Max Neeman International – A leading Contract Research Organization (CRO) based out of India provides full range of clinical research services to global pharmaceutical, biotech and devices companies.

• Based out of 5 regional offices, Max Neeman International has access to hospitals and health care facilities across India.

• Operational since 2001, Max Neeman International has been awarded 150 trials for global sponsors across wide range of therapeutic areas.

• Max Neeman International has been awarded ISO 9001:2000 certification by United Kingdom Accreditation Service (UKAS) for Site Management, Monitoring and Data Management.

• We are presently active in 102 sites in 22 cities with access to 800 ICH-GCP trained Investigators.

• Record of maintaining a patient retention rate between 98.1 to 98.4% across different therapeutic areas.

• Successfully completed 4 US FDA GCP Audits for highest enrollment globally.